Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(25%)
Terminated
1(25%)

Phase Distribution

Ph phase_3
1
25%
Ph not_applicable
1
25%
Ph phase_2
2
50%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Terminated(2)

Detailed Status

Recruiting1
Withdrawn1
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (50.0%)
Phase 31 (25.0%)
N/A1 (25.0%)

Trials by Status

recruiting125%
withdrawn125%
not_yet_recruiting125%
terminated125%

Recent Activity

1 active trials
Showing 4 of 4
not_yet_recruitingphase_2

Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer

NCT07101666
recruitingphase_3

Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)

NCT06392906
terminatednot_applicable

Study of Short Course Radiation Therapy for Elderly Patients With Rectal Cancer

NCT04139967
withdrawnphase_2

Neoadjuvant Therapy for Localized Rectal Adenocarcinoma

NCT04418895

Clinical Trials (4)

Showing 4 of 4 trials
NCT07101666Phase 2

Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer

Not Yet Recruiting
NCT06392906Phase 3

Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)

Recruiting
NCT04139967Not Applicable

Study of Short Course Radiation Therapy for Elderly Patients With Rectal Cancer

Terminated
NCT04418895Phase 2

Neoadjuvant Therapy for Localized Rectal Adenocarcinoma

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
4